PhotoCure ASA (OSTO:PHOO) ROCE % : 4.60% (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is PhotoCure ASA ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. PhotoCure ASA's annualized ROCE % for the quarter that ended in Mar. 2024 was 4.60%.

PhotoCure ASA ROCE % Historical Data

The historical data trend for PhotoCure ASA's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PhotoCure ASA ROCE % Chart

PhotoCure ASA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

23.22

-5.73

-1.14

-7.02

5.80

PhotoCure ASA Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															-1.20	13.39	1.76	9.07	4.60

PhotoCure ASA ROCE % Calculation

PhotoCure ASA's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	36.067	/	( ( (719.034 - 104.056)	+	(711.973 - 83.148) )	/ 2 )
	=	36.067	/	( (614.978	+	628.825)	/ 2 )
	=	36.067	/	621.9015
	=	5.80 %

PhotoCure ASA's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	29.076	/	( ( (711.973 - 83.148)	+	(714.611 - 80.197) )	/ 2 )
	=	29.076	/	( ( 628.825	+	634.414 )	/ 2 )
	=	29.076	/	631.6195
	=	4.60 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

PhotoCure ASA (OSTO:PHOO) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

PhotoCure ASA ROCE % Related Terms

Thank you for viewing the detailed overview of PhotoCure ASA's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

PhotoCure ASA (OSTO:PHOO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PhotoCure ASA (OSTO:PHOO) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

PHO:Norway 0IMT:UK

Address

Hoffsveien 4, Oslo, NOR, 0275

Website

https://www.photocure.com

PhotoCure ASA is a Norway-based business group associated with the research, development, production, distribution, marketing, and sales of pharmaceutical products specialty pharmaceutical companies. Its technology platform is focused on the field of photodynamic diagnosis and treatment of cancer. It has two operating segments of the group the Commercial franchise and the Development portfolio. It generates prime revenue from the Commercial franchise segment, which includes Hexvix and Cysview products. Its geographical segments are Nordic countries, Germany, France, Austria, the United Kingdom, Netherlands, Other European countries, and the United States.

PhotoCure ASA (OSTO:PHOO) Headlines

No Headlines